The genomic landscape of CYP2D6 variation in the Indian population

Ambily Sivadas,Surabhi Rathore,S Sahana,Bani Jolly,Rahul C Bhoyar,Abhinav Jain,Disha Sharma,Mohamed Imran,Vigneshwar Senthilvel,Mohit Kumar Divakar,Anushree Mishra,Sridhar Sivasubbu,Vinod Scaria
DOI: https://doi.org/10.2217/pgs-2023-0233
2024-03-03
Pharmacogenomics
Abstract:Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles ( *86 , *7 , *111 , *112 , *113 , *99 ) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
pharmacology & pharmacy
What problem does this paper attempt to address?